Atai Life Sciences N.V.
NASDAQ: ATAI
$3.16
-$0.32 (-9.2%)
Closing price December 6, 2022
Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to watch for in 2022.
10 months ago
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.
1 year ago